Patient records – access and ownership

From cyber security to protecting business interests, there are a host of considerations surrounding patient records. KAREN CROUCH drills down into this crucial facet of practice management. Read more

Eyecare in a pandemic: counting the cost of missed appointments

The nation’s first comprehensive look at the impact of reduced optometry services due to the COVID-19 lockdown has been provided in new Specsavers data. Australia and New Zealand optometry director Dr BENJAMIN ASHBY delves into the statistics and outlines a plan to manage the patient backlog.

Read more

Eylea biosimilar embarks on Phase 3 trial

A biopharmaceutical company that is developing cheaper anti-VEGF treatments for Australia and other markets has launched a global clinical trial for a biosimilar version of leading treatment Eylea (aflibercept). Read more

Upward trajectory: Eyecare sector charts recovery path

Following the COVID-19 peak, Insight issued a sentiment survey to understand the eyecare sector’s views on topics ranging from the government’s crisis response to industry confidence. Here, we reveal the findings and talk to business owners about their experiences. Read more